Back to Search Start Over

argenx Reports First Quarter 2024 Financial Results and Provides Business Update

Source :
GlobeNewswire. May 9, 2024
Publication Year :
2024

Abstract

$398 million in first quarter global net product sales FDA review ongoing for CIDP sBLA with PDUFA target action date of June 21, 2024 On track to submit filing for [...]

Subjects

Subjects :
Banking, finance and accounting industries
Business
Vyvgart (Medication)

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.793149312

Tools

Authors Abstract Subjects Details